
MedTech company, Intercus GmbH, receives seven-figure growth investment from bm|t
bm|t, the leading growth investor in Thüringen, Germany, has invested a seven-figure sum in Intercus GmbH from Bad Blankenburg.
For over 15 years, Intercus GmbH has produced innovative implants for the trauma and orthopedic markets. With this investment the company plans to bring further innovative products to market and drive its sales growth.
Thomas Busch, CEO, is convinced that Intercus has found a reliable and forward-thinking investor to help the company capitalize on attractive growth opportunities.
bm|t invested in Intercus via one of its managed funds, the Mittelstands-Fonds Thüringen (MFT). The MFT fund invests in established mid-sized companies that have strong growth potential.
More information about Intercus can be found here: https://www.intercus.de